In the studies assessed in this review, sensitivity and specificity were not convincingly high, nor superior to other diagnostic methods such as serum CEA and CA 19-9, and many cancers would not be detected with IL-6 as the diagnostic biomarker. The gene discussed is CEACAM5; the disease is cancer.